Company News, Patents

No-synthase Inhibitors


Patent No. US 7,083,799 B1: L’Oréal, Paris France, patented no-synthase inhibitors comprising of at least one cosmetic or pharmaceutical product capable of causing a cutaneous irritant effect and at least one topically applied nitric oxide synthase inhibitor.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters